Last reviewed · How we verify
NCT03086889
Immersive Virtual Reality Based Training for Rehabilitation of Subacute Stroke
NA trial testing immersion virtual reality (VR)-based rehabilitation in Immersion Virtual Reality Training ,Stroke, Upper Extremity, Randomized Controlled Trial in 40 participants. Terminated before completion.
1 May 2022
Quick facts
| Lead sponsor | Second Affiliated Hospital of Wenzhou Medical University |
|---|---|
| Phase | NA |
| Status | Terminated |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | treatment |
| Enrollment | 40 |
| Start date | 20 April 2017 |
| Primary completion | 1 May 2022 |
| Estimated completion | 1 January 2023 |
| Sites | 1 location across China |
Drugs / interventions tested
- immersion virtual reality (VR)-based rehabilitation
- traditional rehabilitation training
Conditions studied
- Immersion Virtual Reality Training ,Stroke, Upper Extremity, Randomized Controlled Trial — all drugs for Immersion Virtual Reality Training ,Stroke, Upper Extremity, Randomized Controlled Trial →
Sponsor
Second Affiliated Hospital of Wenzhou Medical University
Who can join
Adults 30 to 80, any sex, with Immersion Virtual Reality Training ,Stroke, Upper Extremity, Randomized Controlled Trial. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The investigators will conduct a single-blind, randomized controlled trial of 60 patients with subacute stroke. Patients will be randomly assigned into a control group and an intervention group. The intervention group will participate in immersion VR training for 3 weeks. The control group will receive for traditional rehabilitation training for 3 weeks. Then, the patients will be reevaluated to determine changes in upper extremity function, cognitive function, cortical and subcortical activation patterns, and performance of activities of daily living after the baseline assessment.
Publications & conference data
3 peer-reviewed publications reference this trial (live from Europe PMC):
-
Evaluating the effect and mechanism of upper limb motor function recovery induced by immersive virtual-reality-based rehabilitation for subacute stroke subjects: study protocol for a randomized controlled trial.
Huang Q, Wu W, Chen X, Wu B, et al · · 2019 · cited 30× · PMID 30728055 · DOI 10.1186/s13063-019-3177-y -
Immersive virtual reality-based rehabilitation for subacute stroke: a randomized controlled trial.
Huang Q, Jiang X, Jin Y, Wu B, et al · · 2024 · cited 23× · PMID 37947856 · DOI 10.1007/s00415-023-12060-y -
Using Virtual Reality to Improve Outcomes Related to Quality of Life Among Older Adults With Serious Illnesses: Systematic Review of Randomized Controlled Trials.
Maheta B, Kraft A, Interrante N, Fereydooni S, et al · · 2025 · cited 10× · PMID 40009834 · DOI 10.2196/54452
Verify or expand the search:
- PubMed search for NCT03086889
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other Second Affiliated Hospital of Wenzhou Medical University trials
Trials by the same sponsor.
- NCT07466511 — Effect of Bifidobacterium Breve Supplementation on the Onset and Progression of Idiopathic Scoliosis · NA · not yet recruiting
- NCT07530848 — Perioperative Pharmacokinetics of Anesthetic Drugs and Complications in Overweight and Obese Patients · not yet recruiting
- NCT07346443 — Mechanism Study of G Protein-coupled Receptor 81 in Multiple Organ Dysfunction of Heat Stroke · not yet recruiting
- NCT07353970 — Mechanisms of Prognostic Regulation andPrecision Phenotype Ldentification in Severe Infections Driven by SpecializedPro- · not yet recruiting
- NCT07332793 — Mechanisms of Precise Immune Cell Phenotyping and Prognostic Prediction in Severe Infection · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03086889 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Second Affiliated Hospital of Wenzhou Medical University
- Last refreshed: 18 January 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03086889.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing